ICD-10 Coding for Immune Thrombocytopenic Purpura(D69.3, D69.3B, D69.3D)
Learn about the ICD-10 coding for immune thrombocytopenic purpura (ITP), including documentation requirements, coding pitfalls, and billing considerations.
Complete code families applicable to Immune Thrombocytopenic Purpura
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D69.3 | Immune thrombocytopenic purpura | Use when ITP is confirmed and no secondary causes are identified. |
|
| D69.4 | Other primary thrombocytopenia | Use when primary thrombocytopenia is confirmed but not immune-mediated. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutImmune Thrombocytopenic Purpura
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Immune Thrombocytopenic Purpura.
Failure to document exclusion of secondary causes
Impact
Clinical: Potential misdiagnosis of ITP, Regulatory: Non-compliance with coding standards, Financial: Incorrect billing and reimbursement
Mitigation
Thorough review of patient history, Comprehensive lab testing
Using D69.3 without confirming exclusion of secondary causes
Impact
Reimbursement: May lead to incorrect DRG assignment and reimbursement issues, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Ensure all secondary causes are ruled out before using D69.3
Documentation of secondary causes
Impact
Failure to document exclusion of secondary causes can lead to audit issues.
Mitigation
Implement a checklist for exclusion of secondary causes in documentation.